Clinical Trial Update: Long Term Follow up Study of Predictive Markers in GHD and TS Children

View source ↗

Summary

A long-term follow-up study evaluating predictive biomarkers in children with growth hormone deficiency and Turner syndrome. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Turner Syndrome

Drugs mentioned

• Growth Hormone (Somatropin) (somatropin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Growth Hormon Deficiency, Turner Syndrome in Pre-pubertal Children | Status: COMPLETED